Literature DB >> 11237317

Recommendations for the management of behavioral and psychological symptoms of dementia.

N Herrmann1.   

Abstract

BACKGROUND: The behavioral and psychological symptoms of dementia (BPSD) are common, serious problems that impair the quality of life for both patient and caregiver. In order to provide recommendations based upon the best available evidence, a qualitative literature review was performed.
METHODS: A search of the English language medical literature published between 1966 and 2000 was performed. The quality of the studies was assessed by considering the subjects, trial design, analysis and results. Final recommendations were based upon the quality of available evidence.
RESULTS: The management of BPSD begins with a thorough assessment to search for underlying causes of behaviour change. Concomitant medical illness should be treated and sensory impairment ameliorated. Nonpharmacological approaches should be instituted prior to medication use. These interventions include music, light, changes in level of stimulation and specific behavioral techniques. Antipsychotics are the best studied pharmacological intervention for agitation and aggression and have demonstrated modest but consistent efficacy. Antidepressants such as trazodone and selective serotonin re-uptake inhibitors, as well as anticonvulsants such as carbamazepine and valproic acid have also demonstrated efficacy. Benzodiazepines can be used for short-term treatment as p.r.n. agents when necessary. Pharmacotherapy must be monitored closely for both effectiveness and side effects, with consideration of medication withdrawal when appropriate.
CONCLUSION: The management of BPSD can significantly improve the quality of life for the patient and caregiver. Their assessment and management are essential components of the treatment of dementia.

Entities:  

Mesh:

Year:  2001        PMID: 11237317     DOI: 10.1017/s0317167100001268

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  9 in total

Review 1.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  Serge Gauthier
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

2.  Sensory stimulation in dementia.

Authors:  Alistair Burns; Jane Byrne; Clive Ballard; Clive Holmes
Journal:  BMJ       Date:  2002-12-07

3.  The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.

Authors:  Grace Wu; Krista L Lanctôt; Nathan Herrmann; Shehnaz Moosa; Paul I Oh
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Authors:  Nathan Herrmann; Krista L Lanctôt
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Do atypical antipsychotics cause stroke?

Authors:  Nathan Herrmann; Krista L Lanctôt
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Behavioral and psychological symptoms of dementia and their management.

Authors:  Nilamadhab Kar
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

7.  Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.

Authors:  Chittaranjan Andrade; Rajiv Radhakrishnan
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

8.  Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities.

Authors:  Kang Soo Lee; Sang-Hwan Kim; Hee-Jin Hwang
Journal:  Drugs Real World Outcomes       Date:  2015-11-25

9.  Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.

Authors:  José María García-Alberca; Esther Gris; Paz de la Guía; Silvia Mendoza
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.